ERBB2 and breast cancer: Documenting and describing the relevant sign, symptoms, and impacts from the patient perspective contributes to a deeper understanding of the specific patient experience of HR+/HER2- advanced breast cancer and can provide avenues to identify and target the measurement of treatment outcomes.